141 related articles for article (PubMed ID: 4748451)
1. Topical immunotherapy of basal cell carcinomas with dinitrochlorobenzene.
Levis WR; Kraemer KH; Klingler WG; Peck GL; Terry WD
Cancer Res; 1973 Nov; 33(11):3036-42. PubMed ID: 4748451
[No Abstract] [Full Text] [Related]
2. Review of a 3-year experience with topical chemotherapy and immunotherapy of superficial cutaneous neoplasms.
Cavins JA
J Surg Oncol; 1971; 3(3):325-9. PubMed ID: 5110337
[No Abstract] [Full Text] [Related]
3. Topical treatment of alopecia areata.
Swanson NA; Mitchell AJ; Leahy MS; Headington JT; Diaz LA
Arch Dermatol; 1981 Jul; 117(7):384-7. PubMed ID: 7259216
[TBL] [Abstract][Full Text] [Related]
4. [Comparative topic treatments of basal cell carcinomas and senile keratoses with 5-FU, retinoic acid and DNCB sensitization (author's transl)].
Remy W; Stüttgen G
Dermatologica; 1974; 148(2):72-81. PubMed ID: 4134912
[No Abstract] [Full Text] [Related]
5. Proceedings: Chemotherapy and immunotherapy for cancer involving the skin.
Klein E
Proc Natl Cancer Conf; 1972; 7():567-78. PubMed ID: 4764924
[No Abstract] [Full Text] [Related]
6. [Immunotherapy in dermatology].
Chorzelski T; Langner A; Gliński W
Przegl Dermatol; 1976; (6 Suppl):335-8. PubMed ID: 1032183
[No Abstract] [Full Text] [Related]
7. [Regression of melanoma metastases after immunological therapy].
Malek-Mansour S; Castermans-Elias S; Lapière CM
Dermatologica; 1973; 146(3):156-62. PubMed ID: 4717482
[No Abstract] [Full Text] [Related]
8. Immunotherapeutic approaches to skin cancer.
Klein E
Hosp Pract; 1976 Nov; 11(11):107-16. PubMed ID: 1026608
[TBL] [Abstract][Full Text] [Related]
9. [Immunotherapy with DNCB in mycosis fungoides].
Wätzig V
Dermatol Monatsschr; 1977 Jan; 163(1):56-7. PubMed ID: 838108
[No Abstract] [Full Text] [Related]
10. Scientific rationale: combining imiquimod and surgical treatments for basal cell carcinomas.
Berman B
J Drugs Dermatol; 2008 Jan; 7(1 Suppl 1):s3-6. PubMed ID: 18277456
[TBL] [Abstract][Full Text] [Related]
11. Basal cell nevus syndrome. Unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene.
Hazen PG; Taub SJ
Dermatologica; 1984; 168(6):287-9. PubMed ID: 6745474
[TBL] [Abstract][Full Text] [Related]
12. [DNCB immunotherapy for removal of melanoma skin metastases].
Wätzig V
Dermatol Monatsschr; 1977 Oct; 163(10):848-50. PubMed ID: 923876
[No Abstract] [Full Text] [Related]
13. New perspectives in the management of basal cell carcinoma.
Martín-Gorgojo A; Pastushenko I
Actas Dermosifiliogr; 2014 Nov; 105(9):874-5. PubMed ID: 24934656
[No Abstract] [Full Text] [Related]
14. Failure of topical DNCB immunotherapy in most patients with non-clinical carcinoma of the cervix.
Guthrie D; Way S
Br J Cancer; 1979 Apr; 39(4):445-8. PubMed ID: 444400
[No Abstract] [Full Text] [Related]
15. [Contribution to treatment of malignant melanoblastoma by the local application of DNCB (author's transl)].
Duchková H; Richter J; Kubíková M
Cesk Dermatol; 1978 Jun; 53(3):169-72. PubMed ID: 679282
[No Abstract] [Full Text] [Related]
16. The failure of immunotherapy with dinitrochlorobenzene and Rhus extract for recurrent conjunctival squamous papillomas.
Novick NL; Bosniak SL
J Dermatol Surg Oncol; 1986 Jun; 12(6):602-5. PubMed ID: 2940277
[TBL] [Abstract][Full Text] [Related]
17. The management of non-melanoma skin cancer.
Campbell FA; Gupta G
Hosp Med; 2005 May; 66(5):288-93. PubMed ID: 15920859
[TBL] [Abstract][Full Text] [Related]
18. Dinitrochlorobenzene immunotherapy of human warts.
Sanders BB; Smith KW
Cutis; 1981 Apr; 27(4):389-92. PubMed ID: 7226890
[TBL] [Abstract][Full Text] [Related]
19. Remission of melanoma with D.N.C.B. treatment.
Malek-Mansour S
Lancet; 1973 Sep; 2(7827):503-4. PubMed ID: 4125022
[No Abstract] [Full Text] [Related]
20. [The nonspecific epifocal Malek-Mansour immunotherapy of malignant cutaneous melanoma using DNCB].
Illig L; Paul E
Hautarzt; 1976 Dec; 27(12):579-87. PubMed ID: 1010745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
